MX2011005604A - Vacuna recombinante para influenza aviar y sus usos. - Google Patents
Vacuna recombinante para influenza aviar y sus usos.Info
- Publication number
- MX2011005604A MX2011005604A MX2011005604A MX2011005604A MX2011005604A MX 2011005604 A MX2011005604 A MX 2011005604A MX 2011005604 A MX2011005604 A MX 2011005604A MX 2011005604 A MX2011005604 A MX 2011005604A MX 2011005604 A MX2011005604 A MX 2011005604A
- Authority
- MX
- Mexico
- Prior art keywords
- influenza
- encompasses
- vaccines
- avian influenza
- influenza vaccine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
- C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/517—Plant cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La presente invención abarca vacunas para influenza, en particular vacunas para influenza aviar. La vacuna puede ser una vacuna subunitaria basada en la hemaglutinina de influenza. La hemaglutinina puede ser expresada en plantas incluyendo la lenteja de agua. La invención también abarca vectores recombinantes que codifican y que expresan antígenos, epítopes o inmunógenos de influenza que se pueden utilizar para proteger a los animales contra la influenza. También abarca un régimen de vacunación compatible con la estrategia DIVA, incluyendo un esquema de inicio-esfuerzo utilizando el vector y vacunas subunitarias.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11849208P | 2008-11-28 | 2008-11-28 | |
PCT/US2009/066146 WO2010063033A2 (en) | 2008-11-28 | 2009-11-30 | Recombinant avian influenza vaccine and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2011005604A true MX2011005604A (es) | 2011-09-01 |
Family
ID=42044426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011005604A MX2011005604A (es) | 2008-11-28 | 2009-11-30 | Vacuna recombinante para influenza aviar y sus usos. |
Country Status (11)
Country | Link |
---|---|
US (1) | US8394384B2 (es) |
EP (3) | EP3168307B1 (es) |
KR (1) | KR101715415B1 (es) |
CN (1) | CN102271704A (es) |
CA (1) | CA2744454C (es) |
GT (1) | GT201100145A (es) |
IL (1) | IL213189A (es) |
MX (1) | MX2011005604A (es) |
MY (1) | MY159543A (es) |
RU (1) | RU2559527C2 (es) |
WO (1) | WO2010063033A2 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2011005604A (es) | 2008-11-28 | 2011-09-01 | Merial Ltd | Vacuna recombinante para influenza aviar y sus usos. |
AR079767A1 (es) | 2009-12-28 | 2012-02-15 | Merial Ltd | Antigeno ndv (virus de la enfermedad de newcastle) recombinante y usos del mismo |
US20110236416A1 (en) * | 2010-03-12 | 2011-09-29 | Jean-Christophe Audonnet | Foot and mouth disease virus recombinant vaccines and uses thereof |
ES2635019T3 (es) * | 2010-10-18 | 2017-10-02 | Intervet International B.V. | Vacuna con vector del herpesvirus de pavo contra la gripe aviar en aves de corral |
CN103357004B (zh) * | 2013-07-23 | 2014-10-01 | 武汉中博生物股份有限公司 | 一种提高禽流感抗原利用率的方法 |
WO2015048129A1 (en) * | 2013-09-24 | 2015-04-02 | CHOI, Duk, Kyung | Avian influenza virus polypeptides and methods of their use |
MX2017005687A (es) | 2014-11-03 | 2017-08-21 | Merial Inc | Metodos para usar formulaciones para vacuna con microagujas para elicitar en animales inmunidad protectora contra virus de la rabia. |
CN107847579A (zh) * | 2014-12-19 | 2018-03-27 | 俄勒冈健康与科学大学 | 人和禽h5n1流感的计算优化的广泛反应性抗原的协同共同给药 |
JOP20190088A1 (ar) | 2016-10-21 | 2019-04-21 | Us Agriculture | نواقل مؤتلفة للتعبير عن مولدات مضاد فيروس انفلونزا الطيور و استخداماتها |
US11529413B2 (en) | 2018-06-12 | 2022-12-20 | Kbio Holdings Limited | Virus and antigen purification and conjugation |
JP7315590B2 (ja) | 2018-06-12 | 2023-07-26 | クビオ・ホールディングス・リミテッド | ウイルスと抗原の精製及び結合 |
US11696948B2 (en) | 2018-06-12 | 2023-07-11 | Kbio Holdings Limited | Vaccines formed by virus and antigen conjugation |
US11690907B2 (en) | 2018-06-12 | 2023-07-04 | Kbio Holdings Limited | Vaccines formed by virus and antigen conjugation |
CN112708599B (zh) * | 2019-10-25 | 2022-02-18 | 中国农业大学 | 一株禽流感病毒疫苗株及其应用 |
CN113913395B (zh) * | 2021-10-19 | 2022-06-14 | 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) | 人工重组的h5n8流感病毒及其制备方法和应用 |
Family Cites Families (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US732638A (en) | 1902-10-20 | 1903-06-30 | Elias M Johnson | Projectile. |
US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
US3531565A (en) * | 1969-09-25 | 1970-09-29 | American Cyanamid Co | Stable adjuvant emulsion compositions comprising hydrated salts of a polyvalent metallic cation and a higher fatty acid |
US5505941A (en) | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
EP0138854B1 (en) | 1983-03-08 | 1992-11-04 | Chiron Mimotopes Pty. Ltd. | Antigenically active amino acid sequences |
US5380831A (en) | 1986-04-04 | 1995-01-10 | Mycogen Plant Science, Inc. | Synthetic insecticidal crystal protein gene |
US4761373A (en) | 1984-03-06 | 1988-08-02 | Molecular Genetics, Inc. | Herbicide resistance in plants |
EP0173552B1 (en) | 1984-08-24 | 1991-10-09 | The Upjohn Company | Recombinant dna compounds and the expression of polypeptides such as tpa |
US4945050A (en) | 1984-11-13 | 1990-07-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
US4963481A (en) | 1985-12-18 | 1990-10-16 | Genetics Institute Inc | Promoter system |
US4968615A (en) | 1985-12-18 | 1990-11-06 | Ciba-Geigy Corporation | Deoxyribonucleic acid segment from a virus |
WO1987004181A1 (en) | 1986-01-08 | 1987-07-16 | Rhone-Poulenc Agrochimie | Haloarylnitrile degrading gene, its use, and cells containing the same |
IE872455L (en) | 1986-09-12 | 1988-03-12 | Lanstrase Ltd | Improved recombinant expression |
GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
DE3743138A1 (de) | 1987-12-18 | 1989-09-14 | Mayr Christian Gmbh & Co Kg | Schleifringlose, elektromagnetische ueberlastkupplung |
US5990387A (en) | 1988-06-10 | 1999-11-23 | Pioneer Hi-Bred International, Inc. | Stable transformation of plant cells |
NZ230375A (en) | 1988-09-09 | 1991-07-26 | Lubrizol Genetics Inc | Synthetic gene encoding b. thuringiensis insecticidal protein |
WO1990010076A1 (en) | 1989-02-24 | 1990-09-07 | Monsanto Company | Synthetic plant genes and method for preparation |
US5879918A (en) | 1989-05-12 | 1999-03-09 | Pioneer Hi-Bred International, Inc. | Pretreatment of microprojectiles prior to using in a particle gun |
US5202422A (en) | 1989-10-27 | 1993-04-13 | The Scripps Research Institute | Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins and method of their use |
AU651101B2 (en) | 1990-04-18 | 1994-07-14 | Plant Genetic Systems N.V. | Modified bacillus thuringiensis insecticidal-crystal protein genes and their expression in plant cells |
US5932782A (en) | 1990-11-14 | 1999-08-03 | Pioneer Hi-Bred International, Inc. | Plant transformation method using agrobacterium species adhered to microprojectiles |
ATE247163T1 (de) | 1991-03-07 | 2003-08-15 | Virogenetics Corp | Gentechnologisch hergestellter stamm für impfstoffe |
TW261517B (es) | 1991-11-29 | 1995-11-01 | Mitsubishi Shozi Kk | |
JP2952041B2 (ja) | 1992-07-27 | 1999-09-20 | パイオニア ハイ−ブレッド インターナショナル,インコーポレイテッド | 培養ダイズ細胞のagrobacterium媒介形質転換の改良法 |
FR2702373B1 (fr) | 1993-03-08 | 1996-06-07 | Rhone Merieux | Emulsions vaccinales fluides eau-dans-l'huile contenant une huile métabolisable. |
AU687961B2 (en) | 1993-11-19 | 1998-03-05 | Biotechnology Research And Development Corporation | Chimeric regulatory regions and gene cassettes for expression of genes in plants |
WO1996034109A1 (en) | 1995-04-25 | 1996-10-31 | Vical Incorporated | Single-vial formulations of dna/lipid complexes |
AU6504796A (en) | 1995-07-20 | 1997-02-18 | Washington State University Research Foundation | Production of secreted foreign polypeptides in plant cell culture |
US5846946A (en) | 1996-06-14 | 1998-12-08 | Pasteur Merieux Serums Et Vaccins | Compositions and methods for administering Borrelia DNA |
FR2751228B1 (fr) | 1996-07-19 | 1998-11-20 | Rhone Merieux | Vaccin polynucleotidique bovin pour voie intradermique |
FR2751226B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies du cheval |
FR2751229B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins |
FR2751224B1 (fr) | 1996-07-19 | 1998-11-20 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs |
FR2751227B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives |
FR2751225B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique aviaire |
US6610661B1 (en) | 1996-10-11 | 2003-08-26 | The Regents Of The University Of California | Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
US6045774A (en) | 1997-01-10 | 2000-04-04 | Epicyte Pharmaceutical Inc. | J chain polypeptide targeting molecule linked to an imaging agent |
US5981840A (en) | 1997-01-24 | 1999-11-09 | Pioneer Hi-Bred International, Inc. | Methods for agrobacterium-mediated transformation |
HUP0004589A3 (en) | 1997-06-30 | 2003-08-28 | Centre Nat Rech Scient | Improved method for transferring nucleic acid into the striped muscle and combination therefor |
US7161064B2 (en) | 1997-08-12 | 2007-01-09 | North Carolina State University | Method for producing stably transformed duckweed using microprojectile bombardment |
US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
US6224882B1 (en) | 1997-11-07 | 2001-05-01 | Protein Science Corp. | Insect cells or fractions as adjuvant for antigens |
FR2778858B1 (fr) | 1998-05-20 | 2000-06-16 | Oreal | Emulsion e/h/e stable et son utilisation comme composition cosmetique et/ou dermatologique |
FR2801607B1 (fr) | 1999-11-26 | 2001-12-28 | Merial Sas | Pneumovirus du canard et vaccins correspondants |
US6852705B2 (en) | 2000-01-21 | 2005-02-08 | Merial | DNA vaccines for farm animals, in particular bovines and porcines |
NZ523912A (en) | 2000-07-31 | 2005-03-24 | Biolex Inc | Expression of biologically active polypeptides in duckweed |
US7709699B2 (en) | 2001-05-30 | 2010-05-04 | Biolex Therapeutics, Inc. | Use of duckweed in high throughput screening |
WO2003030934A2 (en) | 2001-10-06 | 2003-04-17 | Merial Limited | Cpg formulations and related methods |
US6680200B2 (en) | 2002-02-22 | 2004-01-20 | Biolex, Inc. | Led array for illuminating cell well plates and automated rack system for handling the same |
US7176024B2 (en) | 2003-05-30 | 2007-02-13 | Biolex, Inc. | Bioreactor for growing biological materials supported on a liquid surface |
ATE392905T1 (de) | 2003-07-24 | 2008-05-15 | Merial Ltd | Vakzin-formulierungen mit einer öl-in-wasser- emulsion |
US7691368B2 (en) | 2005-04-15 | 2010-04-06 | Merial Limited | Vaccine formulations |
RU2483751C2 (ru) * | 2005-10-18 | 2013-06-10 | Новавакс, Инк. | ФУНКЦИОНАЛЬНЫЕ ВИРУСОПОДОБНЫЕ ЧАСТИЦЫ ГРИППА (VLPs) |
US8883123B2 (en) | 2005-10-28 | 2014-11-11 | Boehringer Ingleheim Vetmedica, Inc. | Use of vaccines for the treatment/prevention of the transmission of pathogens |
US20070286873A1 (en) * | 2006-05-23 | 2007-12-13 | Williams John V | Recombinant Influenza H5 Hemagluttinin Protein And Nucleic Acid Coding Therefor |
RU2323741C2 (ru) * | 2006-06-14 | 2008-05-10 | Федеральное государственное учреждение "Федеральный центр охраны здоровья животных" (ФГУ "ВНИИЗЖ") | Вакцина против гриппа птиц инактивированная эмульсионная |
KR20090101883A (ko) | 2006-10-10 | 2009-09-29 | 더 거번먼트 오브 더 유나이티드 스테이츠 오브 어메리카 애즈 레프리젠티드 바이 더 세크러터리 오브 더 디파트먼트 오브 헬쓰 앤드 휴먼 써비시즈 | 조류 인플루엔자 백신 |
US8202967B2 (en) | 2006-10-27 | 2012-06-19 | Boehringer Ingelheim Vetmedica, Inc. | H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
US20080107687A1 (en) | 2006-11-06 | 2008-05-08 | Herve Poulet | Feline vaccines against avian influenza |
US7910112B2 (en) | 2006-11-06 | 2011-03-22 | Merial Limited | Feline vaccines against avian influenza |
US20100310604A1 (en) | 2007-11-27 | 2010-12-09 | Medicago Inc. | Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin |
MX2011005604A (es) | 2008-11-28 | 2011-09-01 | Merial Ltd | Vacuna recombinante para influenza aviar y sus usos. |
-
2009
- 2009-11-30 MX MX2011005604A patent/MX2011005604A/es active IP Right Grant
- 2009-11-30 KR KR1020117014944A patent/KR101715415B1/ko active IP Right Grant
- 2009-11-30 EP EP16184378.4A patent/EP3168307B1/en active Active
- 2009-11-30 RU RU2011126359/10A patent/RU2559527C2/ru active
- 2009-11-30 EP EP19167414.2A patent/EP3542815A1/en not_active Withdrawn
- 2009-11-30 CN CN2009801534446A patent/CN102271704A/zh active Pending
- 2009-11-30 EP EP09760072.0A patent/EP2367566B2/en active Active
- 2009-11-30 MY MYPI2011002362A patent/MY159543A/en unknown
- 2009-11-30 CA CA2744454A patent/CA2744454C/en not_active Expired - Fee Related
- 2009-11-30 WO PCT/US2009/066146 patent/WO2010063033A2/en active Application Filing
- 2009-11-30 US US12/628,085 patent/US8394384B2/en active Active
-
2011
- 2011-05-27 GT GT201100145A patent/GT201100145A/es unknown
- 2011-05-29 IL IL213189A patent/IL213189A/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
EP3542815A1 (en) | 2019-09-25 |
EP2367566A2 (en) | 2011-09-28 |
CA2744454C (en) | 2020-03-24 |
KR101715415B1 (ko) | 2017-03-10 |
RU2011126359A (ru) | 2013-01-10 |
EP3168307A1 (en) | 2017-05-17 |
WO2010063033A3 (en) | 2010-10-28 |
MY159543A (en) | 2017-01-13 |
KR20110108337A (ko) | 2011-10-05 |
US20100189731A1 (en) | 2010-07-29 |
EP3168307B1 (en) | 2020-07-15 |
CA2744454A1 (en) | 2010-06-03 |
RU2559527C2 (ru) | 2015-08-10 |
EP2367566B2 (en) | 2019-11-27 |
EP2367566B1 (en) | 2016-10-05 |
WO2010063033A2 (en) | 2010-06-03 |
IL213189A (en) | 2015-10-29 |
US8394384B2 (en) | 2013-03-12 |
GT201100145A (es) | 2013-09-30 |
IL213189A0 (en) | 2011-07-31 |
CN102271704A (zh) | 2011-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY159543A (en) | Recombinant avian influenza vaccine and uses thereof | |
MX351643B (es) | Antigeno ndv recombinante y usos del mismo. | |
MX347997B (es) | Vacunas aviares vectorizadas con el virus de la enfermedad de newcastle. | |
NZ602278A (en) | Bluetongue virus recombinant vaccines and uses thereof | |
WO2007024947A3 (en) | Canine influenza vaccines | |
MX344103B (es) | Vacunas de virus herpes vectorizado con virus de enfermedad de newcastle. | |
WO2012106377A3 (en) | Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof | |
IN2012DN06289A (es) | ||
WO2011106607A3 (en) | Subunit vaccines for herpes viruses and methods of use | |
WO2012024621A3 (en) | Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus hemagglutinin | |
MX2014009845A (es) | Vectores poxvirales recombinantes que expresan proteinas tanto de rabia como de ox40, y vacunas hechas a partir de los mismos. | |
NZ700470A (en) | Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein c and uses thereof | |
WO2010048394A3 (en) | Vaccine against african horse sickness virus | |
PH12014501795B1 (en) | Rotavirus subunit vaccines and methods of making and use thereof | |
MX2015013304A (es) | Vacunas de nucleoproteina de la influenza. | |
CO6670515A2 (es) | Vectores de parapoxvirus | |
NZ596223A (en) | Combined measles-malaria vaccine | |
GB2515222A (en) | Use of flagellin as a vaccine | |
MX2010008170A (es) | Vacunas para influenza canina. | |
PH12018500372A1 (en) | Fcv recombinant vaccines and uses thereof | |
MX351482B (es) | Vacuna contra el virus sincitial respiratorio (vsr). |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
PD | Change of proprietorship |
Owner name: MERIAL, INC. |